Cargando…
A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis
The effects of an analgesic treatment (lidocaine patches) on brain activity in chronic low back pain (CBP) and in knee osteoarthritis (OA) were investigated using serial fMRI (contrasting fMRI between before and after two weeks of treatment). Prior to treatment brain activity was distinct between th...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584040/ https://www.ncbi.nlm.nih.gov/pubmed/18950528 http://dx.doi.org/10.1186/1744-8069-4-47 |
_version_ | 1782160766953062400 |
---|---|
author | Baliki, Marwan N Geha, Paul Y Jabakhanji, Rami Harden, Norm Schnitzer, Thomas J Apkarian, A Vania |
author_facet | Baliki, Marwan N Geha, Paul Y Jabakhanji, Rami Harden, Norm Schnitzer, Thomas J Apkarian, A Vania |
author_sort | Baliki, Marwan N |
collection | PubMed |
description | The effects of an analgesic treatment (lidocaine patches) on brain activity in chronic low back pain (CBP) and in knee osteoarthritis (OA) were investigated using serial fMRI (contrasting fMRI between before and after two weeks of treatment). Prior to treatment brain activity was distinct between the two groups: CBP spontaneous pain was associated mainly with activity in medial prefrontal cortex, while OA painful mechanical knee stimulation was associated with bilateral activity in the thalamus, secondary somatosensory, insular, and cingulate cortices, and unilateral activity in the putamen and amygdala. After 5% lidocaine patches were applied to the painful body part for two weeks, CBP patients exhibited a significant decrease in clinical pain measures, while in OA clinical questionnaire based outcomes showed no treatment effect but stimulus evoked pain showed a borderline decrease. The lidocaine treatment resulted in significantly decreased brain activity in both patient groups with distinct brain regions responding in each group, and sub-regions within these areas were correlated with pain ratings specifically for each group (medial prefrontal cortex in CBP and thalamus in OA). We conclude that the two chronic pain conditions involve distinct brain regions, with OA pain engaging many brain regions commonly observed in acute pain. Moreover, lidocaine patch treatment modulates distinct brain circuitry in each condition, yet in OA we observe divergent results with fMRI and with questionnaire based instruments. |
format | Text |
id | pubmed-2584040 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-25840402008-11-18 A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis Baliki, Marwan N Geha, Paul Y Jabakhanji, Rami Harden, Norm Schnitzer, Thomas J Apkarian, A Vania Mol Pain Research The effects of an analgesic treatment (lidocaine patches) on brain activity in chronic low back pain (CBP) and in knee osteoarthritis (OA) were investigated using serial fMRI (contrasting fMRI between before and after two weeks of treatment). Prior to treatment brain activity was distinct between the two groups: CBP spontaneous pain was associated mainly with activity in medial prefrontal cortex, while OA painful mechanical knee stimulation was associated with bilateral activity in the thalamus, secondary somatosensory, insular, and cingulate cortices, and unilateral activity in the putamen and amygdala. After 5% lidocaine patches were applied to the painful body part for two weeks, CBP patients exhibited a significant decrease in clinical pain measures, while in OA clinical questionnaire based outcomes showed no treatment effect but stimulus evoked pain showed a borderline decrease. The lidocaine treatment resulted in significantly decreased brain activity in both patient groups with distinct brain regions responding in each group, and sub-regions within these areas were correlated with pain ratings specifically for each group (medial prefrontal cortex in CBP and thalamus in OA). We conclude that the two chronic pain conditions involve distinct brain regions, with OA pain engaging many brain regions commonly observed in acute pain. Moreover, lidocaine patch treatment modulates distinct brain circuitry in each condition, yet in OA we observe divergent results with fMRI and with questionnaire based instruments. BioMed Central 2008-10-25 /pmc/articles/PMC2584040/ /pubmed/18950528 http://dx.doi.org/10.1186/1744-8069-4-47 Text en Copyright © 2008 Baliki et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Baliki, Marwan N Geha, Paul Y Jabakhanji, Rami Harden, Norm Schnitzer, Thomas J Apkarian, A Vania A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis |
title | A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis |
title_full | A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis |
title_fullStr | A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis |
title_full_unstemmed | A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis |
title_short | A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis |
title_sort | preliminary fmri study of analgesic treatment in chronic back pain and knee osteoarthritis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584040/ https://www.ncbi.nlm.nih.gov/pubmed/18950528 http://dx.doi.org/10.1186/1744-8069-4-47 |
work_keys_str_mv | AT balikimarwann apreliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis AT gehapauly apreliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis AT jabakhanjirami apreliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis AT hardennorm apreliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis AT schnitzerthomasj apreliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis AT apkarianavania apreliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis AT balikimarwann preliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis AT gehapauly preliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis AT jabakhanjirami preliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis AT hardennorm preliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis AT schnitzerthomasj preliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis AT apkarianavania preliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis |